- Home
- ITRG vs VSTM Comparison
ITRG vs VSTM Comparison
Compare ITRG & VSTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ITRG
- VSTM
- Stock Information
- Founded
- ITRG 1997
- VSTM 2010
- Country
- ITRG Canada
- VSTM United States
- Employees
- ITRG N/A
- VSTM N/A
- Industry
- ITRG Precious Metals
- VSTM Biotechnology: Pharmaceutical Preparations
- Sector
- ITRG Basic Materials
- VSTM Health Care
- Exchange
- ITRG Nasdaq
- VSTM Nasdaq
- Market Cap
- ITRG 523.9M
- VSTM 581.6M
- IPO Year
- ITRG N/A
- VSTM 2012
- Fundamental
- Price
- ITRG $2.75
- VSTM $8.00
- Analyst Decision
- ITRG Strong Buy
- VSTM Strong Buy
- Analyst Count
- ITRG 2
- VSTM 9
- Target Price
- ITRG $4.00
- VSTM $13.38
- AVG Volume (30 Days)
- ITRG 2.0M
- VSTM 2.9M
- Earning Date
- ITRG 11-12-2025
- VSTM 11-04-2025
- Dividend Yield
- ITRG N/A
- VSTM N/A
- EPS Growth
- ITRG N/A
- VSTM N/A
- EPS
- ITRG 0.09
- VSTM N/A
- Revenue
- ITRG $148,447,000.00
- VSTM $13,379,000.00
- Revenue This Year
- ITRG $871.24
- VSTM $88.60
- Revenue Next Year
- ITRG $2.41
- VSTM $416.99
- P/E Ratio
- ITRG $29.80
- VSTM N/A
- Revenue Growth
- ITRG N/A
- VSTM 33.79
- 52 Week Low
- ITRG $0.79
- VSTM $3.46
- 52 Week High
- ITRG $3.49
- VSTM $11.25
- Technical
- Relative Strength Index (RSI)
- ITRG 45.57
- VSTM 43.46
- Support Level
- ITRG $2.68
- VSTM $7.55
- Resistance Level
- ITRG $2.86
- VSTM $10.09
- Average True Range (ATR)
- ITRG 0.17
- VSTM 0.64
- MACD
- ITRG -0.04
- VSTM -0.09
- Stochastic Oscillator
- ITRG 28.19
- VSTM 16.54
About ITRG Integra Resources Corp.
Integra Resources Corp is a precious metals exploration and development company in the Great Basin of the Western USA. Integra is currently focused on advancing its two flagship oxide heap leach projects: the past-producing DeLamar Project located in southwestern Idaho and the Nevada North Project, comprised of the Wildcat and Mountain View deposits, located in northwestern Nevada. The company also holds a portfolio of prospective early-stage exploration projects in Idaho, Nevada, and Arizona.
About VSTM Verastem Inc.
Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.